- NACDS, NCPA, GPhA express support for Drug Quality and Security Act
- Facing pharmacy trends for the remainder of the year
- State of the market: Are generic drugs approaching their peak?
- Generic drug prices spike, but PBMs' reimbursement rates don't keep up, NCPA study finds
- Senate passes Drug Quality and Security Act
WASHINGTON — The Generic Pharmaceutical Association has promoted Jason Money to associate VP federal government affairs, the trade group said Monday.
Money, who has worked for the GPhA for six years, was previously the organization's senior director for federal affairs. In the new position, he will continue lobbying on behalf of the generic drug industry in Congress.
"Jason brings an unmatched passion to GPhA legislative affairs," GPhA president and CEO Ralph Neas said. "We are thrilled to recognize his exceptional work on behalf of an industry helping to ensure that our nation's policies continue to protect and encourage the important role generics and biosimilars play, bending the health cost curve and improving lives."